IPP Bureau
Merus and Halozyme collaborate to advance subcutaneous Petosemtamab development
By IPP Bureau - November 18, 2025
Merus has licensed Halozyme’s proprietary ENHANZE technology to develop and commercialize subcutaneous formulations of petosemtamab
Ingenus Pharma launches first FDA-approved generic version of Premarin
By IPP Bureau - November 18, 2025
Conjugated Estrogens Tablets are indicated for moderate to severe menopausal symptoms, including hot flashes, and for the prevention of postmenopausal osteoporosis in women at significant risk
New England Biolabs unveils high-speed flu sequencing tool to bolster global outbreak surveillance
By IPP Bureau - November 18, 2025
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Akums launches 14th free plastic surgery camp in Haridwar
By IPP Bureau - November 18, 2025
The ten-day initiative, running from 10 to 21 November, brings together a team of highly skilled German doctors providing life-changing reconstructive surgeries at no cost
XenoTherapeutics to acquire Repare Therapeutics
By IPP Bureau - November 17, 2025
Lupin launches long-acting Risperidone in US
By IPP Bureau - November 17, 2025
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
CIAN Agro to market Andhra Pradesh Medtech Zone’s medical device
By IPP Bureau - November 17, 2025
SPARC announces consolidation of R&D laboratories and facilities
By IPP Bureau - November 17, 2025
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
Remedium Lifecare posts consolidated Q2 FY26 net profit higher at Rs. 8.62 Cr
By IPP Bureau - November 17, 2025
Consolidated revenue from operations stood at Rs. 111.05 crore
Samson Clinical completes patient recruitment for clinical trial of male-pattern baldness drug
By IPP Bureau - November 17, 2025
AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India
By IPP Bureau - November 17, 2025
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Briefs: Zydus, Divi's Laboratories and Relonchem
By IPP Bureau - November 17, 2025
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
WHO issues first global guidelines for managing diabetes in pregnancy
By IPP Bureau - November 17, 2025
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
EMA recommends authorization of Teizeild to delay Type 1 diabetes onset
By IPP Bureau - November 17, 2025
This is the first drug to receive a recommendation for this preventative indication in the European Union
FDA concludes Lupin’s Nagpur Unit-1 facility inspection with zero observations
By IPP Bureau - November 16, 2025
